Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.

The approval was based on a multicenter, randomized, evaluator-blinded, split-hand study (N=89) which showed that treatment with Restylane Lyft resulted in a clinically meaningful improvement in the ...

SCOTTSDALE, Ariz., April 27, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel (the ...

April 27, 2011 — Today, the US Food and Drug Administration's General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee recommended the injectable wrinkle-filler Restylane ...

Please provide your email address to receive an email when new articles are posted on . Restylane Eyelight is the first U.S. product formulated with non-animal stabilized hyaluronic acid technology ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted market approval to Restylane Lyft with lidocaine for cheek augmentation and correction of ...

Are you always on the hunt for a way to iron out the time lines etched in your face? Behold: a new study has found that multiple injections of Restylane, a popular "skin filler" believed to ...